United Biomedical Inc., 10% Owner at Vaxxinity, Inc. (VAXX), bought 41,017 shares at $3.58 ($142K) on 2022-04-27, disclosed to the SEC on 2022-04-28.
Scheduled purchase ($142k) by 10% Owner under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.45 | 18,105 | $62K | 43.9% |
| 2 | $3.45 | 18,105 | $62K | 43.9% |
| 3 | $3.58 | 4,807 | $17K | 12.1% |
| Total | $3.47 avg | 41,017 | $142K | 100% |
| Filing → |
| VAXX | BUY | 2022-04-27 | $27K | — | Filing → |